StockNews.com assumed coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research report report published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
VBI Vaccines Stock Performance
Shares of VBIV stock opened at $0.02 on Friday. VBI Vaccines has a fifty-two week low of $0.06 and a fifty-two week high of $1.35. The company has a 50 day moving average price of $0.35 and a 200 day moving average price of $0.52.
About VBI Vaccines
Further Reading
- Five stocks we like better than VBI Vaccines
- What Are Dividend Challengers?
- 3 Small Cap Stocks That Insiders Are Buying
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- Stock Dividend Cuts Happen Are You Ready?
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.